How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Shangtang Technology completed the placement of a number of international funds, long-term funds and existing shareholders of about HK$ 2.8 billion. For the news that Shang Tang announced today that it plans to place 1.865 billion shares and raise HK$ 2.787 billion, the reporter learned that a number of internationally renowned funds, long-term funds and existing shareholders will participate, and the funds raised will be used to support the company's core business development, including building an industry AI cloud, upgrading the scale of Shang Tang's large-scale devices, supporting generative artificial intelligence, including large-scale model research and product development, and (science and technology innovation board Daily)Shandong mining machine opened at a daily limit, and yesterday it staged the "Earth-Sky Board".
Treasury futures collectively opened lower, with 30-year main contracts down 0.38%, 30-year main contracts down 0.38%, 10-year main contracts down 0.11%, 5-year main contracts down 0.06% and 2-year main contracts down 0.04%.The central bank conducted a 7-day reverse repurchase operation of 78.6 billion yuan today, and the winning bid rate was 1.50%, which was the same as before. As 41.3 billion yuan of 7-day reverse repurchase expired today, the net investment on that day was 37.3 billion yuan.Argentine President Millay: It is planned to cancel capital controls next year. Argentine President Millay said in a televised speech on December 10 local time that Argentina plans to cancel capital controls next year. Millay said that Argentina's economic team is preparing for structural tax reform, which will abolish 90% of the tax revenue, and the Argentine government will continue to ban institutions, secretariats, deputy secretariats, public companies and every state institution that should not exist in the new year. Demián Reidel, economic adviser to Milai, will announce Argentina's nuclear energy plan in the next few days.
Shanghai Electric discussed new energy cooperation with South Korea's Hyosung Group. According to Shanghai Electric, on the morning of December 9, Leo, Party Secretary and Chairman of Shanghai Electric Group, went to Seoul, South Korea to visit South Korea's Hyosung Group and held talks with its president Zhao Xianjun. The two sides had in-depth exchanges on joint ventures and cooperation in the field of new energy. Zhao Xianjun expressed the hope that the two sides will strengthen cooperation in the fields of wind power and hydrogen energy and jointly explore Korean and overseas markets. During the talks, the two sides also discussed the cooperation potential in the fields of hydrogen energy and power grid equipment, and sought cooperation opportunities in technology research and development, project investment and market development.The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.The change in the concept of computing power leasing has increased the daily limit of Yakang shares and Chengdi Xiangjiang, and the concept of computing power leasing has increased. Both Yakang shares and Chengdi Xiangjiang have daily limit, and Runze Technology, Yunsai Zhilian, Tongniu Information and Kehua Data have followed suit.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14